The team led by Wang Ji, a researcher at the Institute of Precision Medicine of the First Affiliated Hospital of Sun Yat-sen University, in collaboration with the team led by Lu Lu and the team led by Zeng Yingyue, has spent six years developing the world's first novel vaccine adjuvant with antigen endoplasmic reticulum targeting function, which facilitates the"last mile"delivery of antigens within cells.
#CancerPrevention #vaccine #innovation
By Lin Jie, Lu Qingyu and Chen Xiaoran(Intern)/China Youth Daily
Photo Source: the interviewee
来源:中国青年报客户端
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.